欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2000, Vol. 5 ›› Issue (3): 242-244.

• 论著 • 上一篇    下一篇

瑞巴匹特在消化性溃疡患者体内的药物动力学

祖鲁宁, 李莉, 于大海   

  1. 解放军404医院药剂科,威海264200
  • 收稿日期:2000-01-27 修回日期:2000-05-15 出版日期:2000-09-26 发布日期:2020-11-25
  • 作者简介:祖鲁宁,男,37岁,主管药师,主要从事医院药学工作。

Pharmacokinetics of rebamipide in the patients with peptic ulcer

ZU Lu-Ning, LI Li YU Da-Hai   

  1. Department of Pharmacy,The 404th Hospi tal of PL A,Weihai 264200
  • Received:2000-01-27 Revised:2000-05-15 Online:2000-09-26 Published:2020-11-25

摘要: 目的 观察瑞巴匹特在消化性溃疡患者体内的药物动力学。方法 27 例消化性溃疡患者随机分成2组,分别单剂量口服国产或进口瑞巴匹特600mg,用高效液相色谱法测定口服后不同时间的血药浓度,模拟房室模型并计算药物动力学参数。结果 国产和进口瑞巴匹特单剂量口服后的血药浓度- 时间曲线均符合一级吸收开放二室模型,主要药动学参数Cmax分别为(0.56 ±0.24)和(0.59 ±0.29)mg·L-1,tmax为(1.75±0.92)和(1.98±1.05)h,t1/2(β)分别为(1.86±1.38)和(1.93 ±1.45)h,AUC0~∞为(2.48 ±1.06)和(2.62±1.35)mg·h·L-1 ,经统计学分析无明显差别(P>0.05);以进口药物为参比,国产药物相对生物利用度为94.66 %。结论 国产瑞巴匹特与进口制剂具有相同动力学特性。

关键词: 瑞巴匹特, 药物动力学, 高效液相色谱

Abstract: Aim The pharmacokinetics of rebamipide domestic and imported pro ducts in 27 patients with peptic ulcer was investigated.Methods The rebamipide concentrations in plasma were determined by high performance liquid chromatographic method following a single oral dose of 600 mg rebamipide made either in China or in Japan.The pharmaco kinetic parameters were computed with PKBP-N1 program.Results Following a single oral dose of rebamipide, the concentration-time curves of the domestic and imported products fitted to two compartment open model.There was no significant difference in each pharmacokinetic parameters between the two product s(P>0.05). Cmax of domestic and imported rebamipide tablet were (0.56±0.24) and (0.59±0.29)mg·L-1,with that tmax were (1.75±0.92)and (1.98±1.05) h, t1/2(β) were (1.86±1.38)and (1.93±1.45)h, AUC0~∞ were (2.48±1.06) and (2.62±1.35)mg·h·L-1. Conclusion The pharmacokinetics of the two products are similar.

Key words: rebamipide, pharmacokinetics, high performance liquid chromatographic

中图分类号: